Skin Protectant

DermaRite Industries, LLC has initiated a Class II recall for McKesson Skin Protectant, Lanolin USP, citing Current Good Manufacturing Practice (CGMP) deviations. Products manufactured at its North Bergen, NJ facility were found to be contaminated, posing a significant risk to supply chains. Procurement and regulatory teams must assess immediate inventory impacts and re-evaluate supplier quality oversight.

PREQUEL SKIN has initiated a voluntary Class II recall of 30,946 tubes of BARRIER THERAPY SKIN PROTECTANT CREAM due to microbial contamination. This event, impacting nationwide distribution, underscores critical quality control challenges in non-sterile drug products. Decision-makers must assess supply chain vulnerabilities and reinforce sterility assurance protocols to mitigate similar regulatory and reputational risks.

OMEZA LLC has voluntarily recalled 1,210 vials of Omeza Skin Protectant Gel (Lot: 19123 4-1) due to Current Good Manufacturing Practice (CGMP) deviations. This Class II, firm-initiated recall, distributed US nationwide, underscores critical regulatory compliance challenges. Supply chain and regulatory teams must scrutinize supplier quality systems to mitigate similar disruptions and ensure product integrity.